BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang C, Zheng X, Cao S. Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/6775496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou L, Cheng Q, Hu Y, Tan H, Li X, Wu S, Zhou T, Zhou J. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation. Front Oncol 2022;12:1030802. [PMID: 36620545 DOI: 10.3389/fonc.2022.1030802] [Reference Citation Analysis]
2 Li W, Yang G, Dong H, Zhu J, Liu T. A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1055785] [Reference Citation Analysis]
3 Li S, Man Q, Liu B. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.943945] [Reference Citation Analysis]
4 Zhong X, He X, Wang Y, Hu Z, Yu D, Huang H, Zhao S, Wei P, Li D, Zhang X. A Hypoxia-Related lncRNA Signature Correlates with Survival and Tumor Microenvironment in Colorectal Cancer. Journal of Immunology Research 2022;2022:1-23. [DOI: 10.1155/2022/9935705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]